Literature DB >> 16061948

Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux.

Bela F Asztalos1, Margarita de la Llera-Moya, Gerard E Dallal, Katalin V Horvath, Ernst J Schaefer, George H Rothblat.   

Abstract

Our objective was to evaluate the associations of individual apolipoprotein A-I (apoA-I)-containing HDL subpopulation levels with ABCA1- and scavenger receptor class B type I (SR-BI)-mediated cellular cholesterol efflux. HDL subpopulations were measured by nondenaturing two-dimensional gel electrophoresis from 105 male subjects selected with various levels of apoA-I in pre-beta-1, alpha-1, and alpha-3 HDL particles. ApoB-containing lipoprotein-depleted serum was incubated with [(3)H]cholesterol-labeled cells to measure efflux. The difference in efflux between control and ABCA1-upregulated J774 macrophages was taken as a measure of ABCA1-mediated efflux. SR-BI-mediated efflux was determined using cholesterol-labeled Fu5AH hepatoma cells. Fractional efflux values obtained from these two cell systems were correlated with the levels of individual HDL subpopulations. A multivariate analysis showed that two HDL subspecies correlated significantly with ABCA1-mediated efflux: small, lipid-poor pre-beta-1 particles (P=0.0022) and intermediate-sized alpha-2 particles (P=0.0477). With regard to SR-BI-mediated efflux, multivariate analysis revealed significant correlations with alpha-2 (P=0.0004), alpha-1 (P=0.0030), pre-beta-1 (P=0.0056), and alpha-3 (P=0.0127) HDL particles. These data demonstrate that the small, lipid-poor pre-beta-1 HDL has the strongest association with ABCA1-mediated cholesterol even in the presence of all other HDL subpopulations. Cholesterol efflux via the SR-BI pathway is associated with several HDL subpopulations with different apolipoprotein composition, lipid content, and size.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061948     DOI: 10.1194/jlr.M500187-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  85 in total

1.  The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors:  Richard E Morton; Yan Liu
Journal:  J Lipid Res       Date:  2020-06-26       Impact factor: 5.922

2.  A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol.

Authors:  Sandhya Sankaranarayanan; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; Bela F Asztalos; Robert Bittman; George H Rothblat
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

Review 3.  Clinical and biological relevance of statin-mediated changes in HDL metabolism.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

Review 4.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

5.  HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study.

Authors:  R Kannan Mutharasan; C Shad Thaxton; Jarett Berry; Martha L Daviglus; Chun Yuan; Jie Sun; Colby Ayers; Donald M Lloyd-Jones; John T Wilkins
Journal:  J Lipid Res       Date:  2017-01-03       Impact factor: 5.922

6.  Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

Authors:  Frank M Sacks; Lawrence L Rudel; Adam Conner; Hassibullah Akeefe; Gerhard Kostner; Talal Baki; George Rothblat; Margarita de la Llera-Moya; Bela Asztalos; Timothy Perlman; Chunyu Zheng; Petar Alaupovic; Jo-Ann B Maltais; H Bryan Brewer
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

7.  Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice.

Authors:  Junichiro Tohyama; Jeffrey T Billheimer; Ilia V Fuki; George H Rothblat; Daniel J Rader; John S Millar
Journal:  Atherosclerosis       Date:  2008-09-27       Impact factor: 5.162

8.  Acute consumption of walnuts and walnut components differentially affect postprandial lipemia, endothelial function, oxidative stress, and cholesterol efflux in humans with mild hypercholesterolemia.

Authors:  Claire E Berryman; Jessica A Grieger; Sheila G West; Chung-Yen O Chen; Jeffrey B Blumberg; George H Rothblat; Sandhya Sankaranarayanan; Penny M Kris-Etherton
Journal:  J Nutr       Date:  2013-04-24       Impact factor: 4.798

9.  Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.

Authors:  Xin-Min Li; Wai Hong Wilson Tang; Marian K Mosior; Ying Huang; Yuping Wu; William Matter; Vivian Gao; David Schmitt; Joseph A Didonato; Edward A Fisher; Jonathan D Smith; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-21       Impact factor: 8.311

10.  Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux.

Authors:  Sandhya Sankaranarayanan; John F Oram; Bela F Asztalos; Ashley M Vaughan; Sissel Lund-Katz; Maria Pia Adorni; Michael C Phillips; George H Rothblat
Journal:  J Lipid Res       Date:  2008-09-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.